Subscribe
brexit-istock-537519806_andrewlinscott
andrewlinscott / iStockphoto.com
16 November 2018Big Pharma

Brexit draft deal: a welcome step but more certainty needed, say lawyers

While the pharmaceutical industry has welcomed the draft Withdrawal Agreement for the UK’s departure from the EU, more clarity is still needed, lawyers have told LSIPR.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
UK life sciences bodies submit concerns over ‘no deal’ Brexit
12 November 2018   Associations representing the pharmaceutical and biotechnology fields have said that the UK should maintain “close cooperation” with the EU post-Brexit, to ensure that access to safe and effective medicines continues in both markets.
Big Pharma
Pharma organisations underline Brexit concerns in letter to negotiators
19 July 2017   The Association of the British Pharmaceutical Industry and seven other UK and European life sciences bodies have jointly written to the UK and EU Brexit negotiators.


Editor's picks

BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

Editor's picks

Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More on this story

Big Pharma
UK life sciences bodies submit concerns over ‘no deal’ Brexit
12 November 2018   Associations representing the pharmaceutical and biotechnology fields have said that the UK should maintain “close cooperation” with the EU post-Brexit, to ensure that access to safe and effective medicines continues in both markets.
Big Pharma
Pharma organisations underline Brexit concerns in letter to negotiators
19 July 2017   The Association of the British Pharmaceutical Industry and seven other UK and European life sciences bodies have jointly written to the UK and EU Brexit negotiators.

More on this story

Big Pharma
UK life sciences bodies submit concerns over ‘no deal’ Brexit
12 November 2018   Associations representing the pharmaceutical and biotechnology fields have said that the UK should maintain “close cooperation” with the EU post-Brexit, to ensure that access to safe and effective medicines continues in both markets.
Big Pharma
Pharma organisations underline Brexit concerns in letter to negotiators
19 July 2017   The Association of the British Pharmaceutical Industry and seven other UK and European life sciences bodies have jointly written to the UK and EU Brexit negotiators.

More features

Bayer’s Xarelto patent struck down by German court
Teva draws line under asthma inhaler feud with US rival
Xanax owner fends off ‘Canvax’ mark in EU
Four-lawyer team joins Cozen O’Connor’s new San Diego office
WATCH: Beyond patents — the evolving role of IP lawyers in life sciences
Could Apple v Masimo limit patent cases at the ITC?
Eli Lilly strikes again in weight-loss drugs fight
Novartis moves to block cancer drug generic in US